Perioperative chemotherapy with mFOLFOX6 or CAPOX for patients with locally advanced colon cancer (OPTICAL): A multicenter, randomized, phase 3 trial.

被引：0
|
作者：
Hu, Huabin
Huang, Meijin
Li, Yunfeng
Wang, Ziqiang
Wang, Xiaozhong
Liu, Ping
Zhang, Ruyi
Zhang, Hao
Huang, Zhongcheng
Pei, Haiping
Zeng, Yongming
Lai, Jiajun
Chen, Wenbin
Chen, Jiansi
Ding, Zhijie
Wei, Hongbo
Xu, Qingwen
Chen, Jigui
Wang, Jianping
Deng, Yanhong
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3500
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Hasegawa, J.
    Kato, T.
    Nishimura, J.
    Yoshioka, S.
    Noura, S.
    Kagawa, Y.
    Yasui, M.
    Ikenaga, M.
    Murata, K.
    Hata, T.
    Matsuda, C.
    Mizushima, T.
    Yamamoto, H.
    Doki, Y.
    Mori, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis
    Ding, Miaomiao
    Zhang, Jianwei
    Hu, Huabin
    Cai, Yue
    Ling, Jiayu
    Wu, Zehua
    Xie, Xiaoyu
    Li, Jianxia
    Li, Weiwei
    Deng, Yanhong
    CLINICAL COLORECTAL CANCER, 2022, 21 (01) : E12 - E20
  • [33] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Junichi Nishimura
    Junichi Hasegawa
    Takeshi Kato
    Shinichi Yoshioka
    Shingo Noura
    Yoshinori Kagawa
    Masayoshi Yasui
    Masakazu Ikenaga
    Kohei Murata
    Taishi Hata
    Chu Matsuda
    Tsunekazu Mizushima
    Hirofumi Yamamoto
    Yuichiro Doki
    Masaki Mori
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 707 - 716
  • [34] Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
    Nishimura, Junichi
    Hasegawa, Junichi
    Kato, Takeshi
    Yoshioka, Shinichi
    Noura, Shingo
    Kagawa, Yoshinori
    Yasui, Masayoshi
    Ikenaga, Masakazu
    Murata, Kohei
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 707 - 716
  • [35] CAPOX VERSUS MFOLFOX AS ADJUVANT CHEMOTHERAPY IN PATIENTS WITH STAGE 3 COLON CANCER: A COST-EFFECTIVENESS STUDY
    Abuloha, S.
    Li, P.
    Bian, J.
    Guo, Y.
    Shao, H.
    VALUE IN HEALTH, 2022, 25 (07) : S370 - S370
  • [36] A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer.
    Shanda, Safi
    Noonan, Anne M.
    Bekaii-Saab, Tanios S.
    O'Neil, Bert H.
    Sehdev, Amikar
    Shaib, Walid Labib
    Helft, Paul R.
    Loehrer, Patrick J.
    Tong, Yan
    Liu, Ziyue
    El-Rayes, Bassel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer A Phase 3 Randomized Clinical Trial
    Arjona-Sanchez, Alvaro
    Espinosa-Redondo, Esther
    Gutierrez-Calvo, Alberto
    Segura-Sampedro, Juan J.
    Perez-Viejo, Estibalitz
    Concepcion-Martin, Vanessa
    Sanchez-Garcia, Susana
    Garcia-Fadrique, Alfonso
    Prieto-Nieto, Isabel
    Barrios-Sanchez, Pedro
    Torres-Melero, Juan
    Ramirez Faraco, Maria
    Prada-Villaverde, Arancha
    Carrasco-Campos, Joaquin
    Artiles-Armas, Manuel
    Villarejo-Campos, Pedro
    Ortega-Perez, Gloria
    Boldo-Roda, Emrique
    Sanchez-Hidalgo, Juan-Manuel
    Casado-Adam, Angela
    Rodriguez-Ortiz, Lidia
    Aranda, Enrique
    Cano-Osuna, Maria Teresa
    Diaz-Lopez, Cesar
    Romero-Ruiz, Antonio
    Briceno-Delgado, Javier
    Rufian-Pena, Sebastian
    JAMA SURGERY, 2023, 158 (07) : 683 - 691
  • [38] Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial
    Hu, Huabin
    Zhang, Jianwei
    Li, Yunfeng
    Wang, Xiaozhong
    Wang, Ziqiang
    Wang, Hui
    Kang, Liang
    Liu, Ping
    Lan, Ping
    Wu, Xiaojian
    Zhen, Yunhuan
    Pei, Haiping
    Huang, Zhongcheng
    Zhang, Hao
    Chen, Wenbin
    Zeng, Yongming
    Lai, Jiajun
    Wei, Hongbo
    Huang, Xuefeng
    Chen, Jiansi
    Chen, Jigui
    Tao, Kaixiong
    Xu, Qingwen
    Peng, Xiang
    Liang, Junlin
    Cai, Guanfu
    Ding, Kefeng
    Ding, Zhijie
    Hu, Ming
    Zhang, Wei
    Tang, Bo
    Hong, Chuyuan
    Cao, Jie
    Huang, Zonghai
    Cao, Wuteng
    Li, Fangqian
    Wang, Xinhua
    Wang, Chao
    Huang, Yan
    Zhao, Yandong
    Cai, Yue
    Ling, Jiayu
    Xie, Xiaoyu
    Wu, Zehua
    Shi, Lishuo
    Ling, Li
    Liu, Hao
    Wang, Jianping
    Huang, Meijin
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (25)
  • [39] Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)
    Schmoll, Hans-Joachim
    Cunningham, David
    Sobrero, Alberto
    Karapetis, Christos S.
    Rougier, Philippe
    Koski, Sheryl L.
    Kocakova, Ilona
    Bondarenko, Igor
    Bodoky, Gyoergy
    Mainwaring, Paul
    Salazar, Ramon
    Barker, Peter
    Mookerjee, Bijoyesh
    Robertson, Jane
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (29) : 3588 - 3595
  • [40] BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer
    Benson, Al B., III
    Kiss, Igor
    Bridgewater, John
    Eskens, Ferry A. L. M.
    Sasse, Carolyn
    Vossen, Sandra
    Chen, Jihong
    Van Sant, Chip
    Ball, Howard A.
    Keating, Anne
    Krivoshik, Andrew
    CLINICAL CANCER RESEARCH, 2016, 22 (20) : 5058 - 5067
12345